Streptomycin
3 brands · 2 companies · product forms
ATC: A07AA04, J01GA01
Opportunity snapshot
3
brands
2
companies
Rs 1.9
median price
2
price points
1x
price spread
75
confidence %
Who competes here
Top companies by brand count — concentrated market · leader share 67%
2 brands · 67%
1 brands · 33%
Price room
Across observed sources and strengths
CheapestRs 1.9
MedianRs 1.9
Most expensiveRs 1.9
Spread1×
Sources: DRAP-official
Only 2 trusted price points; variation not scored (low data).
Brands & products on the market
Sample of 1 live product for Streptomycin — each links to its own medicine page.
Why this score
Launch attractiveness
40% supply-gap(65) + 25% price-variation(0) + 20% low-competition(95) + 15% supply-disruption(0), damped by confidence(75). Higher = more attractive, less crowded opportunity.
Market saturation
2 canonical companies and 3 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
Only 2 trusted price points; variation not scored (low data).
Regulatory risk
No DRAP alerts on this molecule's brands.
Confidence
Reduced by: sparse price data.
Packaged brief for this moderate opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules